BioCardia Company Profile (OTCMKTS:CDOM)

About BioCardia

BioCardia logoBioCardia, Inc., formerly Tiger X Medical, Inc., is a clinical-stage regenerative medicine company. The Company is engaged in developing therapeutics for cardiovascular diseases. The Company's lead therapeutic candidate is the CardiAMP Cell Therapy System (CardiAMP). It focuses on the Phase III trial for CardiAMP in ischemic systolic heart failure. The Company also offers CardiALLO Cell Therapy System (CardiALLO), an allogeneic off the shelf mesenchymal stem cell product candidate from other donors. It focuses on the Phase II trial for CardiALLO for the treatment of ischemic systolic heart failure. The Company focuses on various fields of autologous and allogeneic cell-based therapies to manage the lives of patients with cardiovascular conditions. CardiAMP is a therapeutic treatment that includes a companion diagnostic. It consists of a cell potency screening test, a point of care cell processing platform and a biotherapeutic delivery system.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: CDOM
  • CUSIP:
Key Metrics:
  • Previous Close: $0.12
  • 50 Day Moving Average: $0.12
  • 200 Day Moving Average: $0.13
  • 52-Week Range: $0.05 - $0.18
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Beta: 0.68
  • Net Margins: 90.58%
  • Return on Equity: 35.22%
  • Return on Assets: 35.02%
  • Current Ratio: 59.03%
Additional Links:
Companies Related to BioCardia:

Analyst Ratings

Consensus Ratings for BioCardia (OTCMKTS:CDOM) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for BioCardia (OTCMKTS:CDOM)
No equities research coverage for this company has been tracked by


Earnings History for BioCardia (OTCMKTS:CDOM)
No earnings announcements for this company have been tracked by


Earnings Estimates for BioCardia (OTCMKTS:CDOM)
No earnings estimates for this company have been tracked by


Dividend History for BioCardia (OTCMKTS:CDOM)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for BioCardia (OTCMKTS:CDOM)
Insider Ownership Percentage: 53.30%
Institutional Ownership Percentage: 0.22%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/10/2016Andrew A. BrooksCEOSell63,560,031$0.10$6,356,003.10View SEC Filing  
5/10/2016Jonathan BrooksDirectorSell31,954,292$0.10$3,195,429.20View SEC Filing  
5/10/2016Phillip Md Et Al FrostMajor ShareholderBuy114,937,148$0.10$11,493,714.80View SEC Filing  
12/10/2015Phillip Md Et Al FrostMajor ShareholderBuy100,000$0.08$8,000.00View SEC Filing  
12/9/2015Phillip Md Et Al FrostMajor ShareholderBuy18,579$0.07$1,300.53View SEC Filing  
12/7/2015Phillip Md Et Al FrostMajor ShareholderBuy500,000$0.07$35,000.00View SEC Filing  
7/17/2015Phillip Md Et Al FrostMajor ShareholderBuy56,100$0.09$5,049.00View SEC Filing  
8/20/2014Phillip Md Et Al FrostMajor ShareholderBuy100,000$0.10$10,000.00View SEC Filing  
8/11/2014Phillip Md Et Al FrostMajor ShareholderBuy50,000$0.11$5,500.00View SEC Filing  
8/1/2014Phillip Md Et Al FrostMajor ShareholderBuy100,000$0.11$11,000.00View SEC Filing  
7/23/2014Phillip Md Et Al FrostMajor ShareholderBuy260,000$0.11$28,600.00View SEC Filing  
5/23/2014Phillip Md Et Al FrostMajor ShareholderBuy100,000$0.09$9,000.00View SEC Filing  
5/19/2014Phillip Md Et Al FrostMajor ShareholderBuy45,700$0.09$4,113.00View SEC Filing  
5/15/2014Phillip Md Et Al FrostMajor ShareholderBuy21,481$0.09$1,933.29View SEC Filing  
5/14/2014Jonathan BrooksDirectorBuy90,000$0.08$7,200.00View SEC Filing  
12/13/2013Thomas H MorganDirectorSell43,000$0.12$5,160.00View SEC Filing  
12/2/2013Thomas H MorganDirectorSell91,350$0.12$10,962.00View SEC Filing  
11/11/2013Thomas H MorganDirectorSell44,000$0.12$5,280.00View SEC Filing  
11/5/2013Thomas H MorganDirectorSell138,462$0.12$16,615.44View SEC Filing  
10/23/2013Jonathan BrooksDirectorSell2,300,000$0.15$345,000.00View SEC Filing  
8/12/2013Andrew A BrooksCEOBuy205,808$0.08$16,464.64View SEC Filing  
1/30/2013Phillip Md Et Al FrostMajor ShareholderBuy194,685$0.07$13,627.95View SEC Filing  
1/14/2013Andrew A BrooksCEOBuy9,000$0.06$540.00View SEC Filing  
1/11/2013Andrew A BrooksCEOBuy760,000$0.06$45,600.00View SEC Filing  
12/31/2012Andrew A BrooksCEOBuy729,205$0.06$43,752.30View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for BioCardia (OTCMKTS:CDOM)
DateHeadline logoBIOCARDIA, INC. : Other Events, Financial Statements and Exhibits (form 8-K) (OTCMKTS:CDOM) - December 31 at 1:48 AM
News IconTrial to Test Stem Cells for Treating Heart Failure (OTCMKTS:CDOM) - December 31 at 1:48 AM logoForm 4 BioCardia, Inc. For: Dec 22 Filed by: STERTZER SIMON H (OTCMKTS:CDOM) - December 28 at 4:16 PM
News IconDevelopments in the World of Small Cap Companies (OTCMKTS:CDOM) - December 27 at 12:26 PM
News IconBioCardia gets new US patent covering method of treating heart attack tissue damage with patient’s own progenitor cells (OTCMKTS:CDOM) - December 27 at 12:26 PM logoInsider Trading Activity BioCardia Inc (NASDAQ:BCDA) – Major Shareholder Sold 19,230,769 shares of Stock (OTCMKTS:CDOM) - December 25 at 11:48 AM logoBioCardia Receives Another US Patent Covering a Method of Treating Heart Attack Tissue Damage with a Patient’s Own Progenitor Cells, Providing Further Protection To Phase III ... (OTCMKTS:CDOM) - December 23 at 4:24 PM
News IconCBS 58 - BioCardia Receives Another US Patent Covering a Method of Treati (OTCMKTS:CDOM) - December 23 at 4:24 PM logoBioCardia Chairman of the Board Letter to Shareholders (OTCMKTS:CDOM) - November 21 at 10:11 PM logoBIOCARDIA, INC. Files SEC form 8-K, Financial Statements and Exhibits (OTCMKTS:CDOM) - October 27 at 9:40 PM
News IconBioCardia closes Tiger X Medical merger (OTCMKTS:CDOM) - October 25 at 8:59 AM logoTiger X Medical, Inc. :CDOM-US: Earnings Analysis: Q3, 2016 By the Numbers : October 24, 2016 (OTCMKTS:CDOM) - October 24 at 4:03 PM logoBioCardia Closes Merger With Tiger X Medical, Inc. (OTCMKTS:CDOM) - October 24 at 9:19 AM logoTIGER X MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) (OTCMKTS:CDOM) - October 18 at 9:06 AM logoTIGER X MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Defin (OTCMKTS:CDOM) - September 9 at 7:52 PM logoTIGER X MEDICAL, INC. Files SEC form 8-K, Other Events (OTCMKTS:CDOM) - September 9 at 7:52 PM logoTIGER X MEDICAL, INC. Files SEC form 10-Q, Quarterly Report (OTCMKTS:CDOM) - September 9 at 7:52 PM logoTIGER X MEDICAL, INC. Financials (OTCMKTS:CDOM) - September 9 at 7:52 PM logoBioCardia, Inc. Signs Merger Agreement with Tiger X Medical, Inc., Secures Funding to Support Further Development of CardiAMP® Cell Therapy System for the Treatment of Heart Failure (OTCMKTS:CDOM) - September 9 at 7:52 PM logoTIGER X MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi (OTCMKTS:CDOM) - September 9 at 7:52 PM


What is BioCardia's stock symbol?

BioCardia trades on the OTCMKTS under the ticker symbol "CDOM."

How do I buy BioCardia stock?

Shares of BioCardia can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of BioCardia stock cost?

One share of BioCardia stock can currently be purchased for approximately $0.12.

BioCardia (OTCMKTS:CDOM) Chart for Friday, February, 24, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for BioCardia (OTCMKTS:CDOM)

Earnings History Chart

Earnings by Quarter for BioCardia (OTCMKTS:CDOM)

Dividend History Chart

Dividend Payments by Quarter for BioCardia (OTCMKTS:CDOM)

Last Updated on 2/24/2017 by Staff